152 related articles for article (PubMed ID: 36084481)
1. Novel biodegradable two-dimensional vanadene augmented photoelectro-fenton process for cancer catalytic therapy.
Nie Y; Zhang W; Xiao W; Zeng W; Chen T; Huang W; Wu X; Kang Y; Dong J; Luo W; Ji X
Biomaterials; 2022 Oct; 289():121791. PubMed ID: 36084481
[TBL] [Abstract][Full Text] [Related]
2. Gold nanobipyramid@copper sulfide nanotheranostics for image-guided NIR-II photo/chemodynamic cancer therapy with enhanced immune response.
Chen Y; Liu P; Zhou C; Zhang T; Zhou T; Men D; Jiang G; Hang L
Acta Biomater; 2023 Mar; 158():649-659. PubMed ID: 36623783
[TBL] [Abstract][Full Text] [Related]
3. NIR-Driven Intracellular Photocatalytic O
Sang D; Wang K; Sun X; Wang Y; Lin H; Jia R; Qu F
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9604-9619. PubMed ID: 33605733
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional MnO
Wang Q; Qu B; Li J; Liu Y; Dong J; Peng X; Zhang R
ACS Appl Mater Interfaces; 2022 Feb; 14(4):4980-4994. PubMed ID: 35050589
[TBL] [Abstract][Full Text] [Related]
5. Multiple therapeutic mechanisms of pyrrolic N-rich g-C
Song S; Yang M; He F; Zhang X; Gao Y; An B; Ding H; Gai S; Yang P
J Colloid Interface Sci; 2023 Nov; 650(Pt B):1125-1137. PubMed ID: 37473473
[TBL] [Abstract][Full Text] [Related]
6. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
Liang R; Li Y; Huo M; Lin H; Chen Y
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
[TBL] [Abstract][Full Text] [Related]
7. 3-Bromopyruvate-Loaded Ti
Wang Z; Li H; She W; Zhang X; Liu Y; Liu Y; Jiang P
Anal Chem; 2023 Jan; 95(2):1710-1720. PubMed ID: 36599415
[TBL] [Abstract][Full Text] [Related]
8. Near infrared-assisted Fenton reaction for tumor-specific and mitochondrial DNA-targeted photochemotherapy.
Hu P; Wu T; Fan W; Chen L; Liu Y; Ni D; Bu W; Shi J
Biomaterials; 2017 Oct; 141():86-95. PubMed ID: 28668609
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of red/black phosphorus-based composite nanosheets with a Z-scheme heterostructure for high-performance cancer phototherapy.
Kang Y; Li Z; Lu F; Su Z; Ji X; Zhang S
Nanoscale; 2022 Jan; 14(3):766-779. PubMed ID: 34951432
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide self-sufficient and glutathione-depleted nanoplatform for boosting chemodynamic therapy synergetic phototherapy.
Zhang H; Han R; Song P; Wei X; Hou Y; Yu J; Tang K
J Colloid Interface Sci; 2023 Jan; 629(Pt A):103-113. PubMed ID: 36054988
[TBL] [Abstract][Full Text] [Related]
12. MoO
Wu F; Zhang Q; Sun B; Chu X; Zhang M; She Z; Li Z; Zhou N; Wang J; Li A
J Control Release; 2021 Oct; 338():46-55. PubMed ID: 34391835
[TBL] [Abstract][Full Text] [Related]
13. Natural Polyphenol-Vanadium Oxide Nanozymes for Synergistic Chemodynamic/Photothermal Therapy.
Chen T; Huang R; Liang J; Zhou B; Guo XL; Shen XC; Jiang BP
Chemistry; 2020 Nov; 26(66):15159-15169. PubMed ID: 32737907
[TBL] [Abstract][Full Text] [Related]
14. All-in-One Theranostic Nanomedicine with Ultrabright Second Near-Infrared Emission for Tumor-Modulated Bioimaging and Chemodynamic/Photodynamic Therapy.
Xu J; Shi R; Chen G; Dong S; Yang P; Zhang Z; Niu N; Gai S; He F; Fu Y; Lin J
ACS Nano; 2020 Aug; 14(8):9613-9625. PubMed ID: 32806021
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
[TBL] [Abstract][Full Text] [Related]
16. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
[TBL] [Abstract][Full Text] [Related]
17. Mild-temperature responsive nanocatalyst for controlled drug release and enhanced catalytic therapy.
Xu M; Xie X; Liu Y; Topham PD; Zeng Y; Zhan J; Wang L; Yu Q
Acta Biomater; 2023 Sep; 167():473-488. PubMed ID: 37271248
[TBL] [Abstract][Full Text] [Related]
18. Highly Efficient GSH-Responsive "Off-On" NIR-II Fluorescent Fenton Nanocatalyst for Multimodal Imaging-Guided Photothermal/Chemodynamic Synergistic Cancer Therapy.
Li H; Liu Y; Huang B; Zhang C; Wang Z; She W; Liu Y; Jiang P
Anal Chem; 2022 Jul; 94(29):10470-10478. PubMed ID: 35816734
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances on NIR-II Light-Enhanced Chemodynamic Therapy.
Wu GL; Tan X; Yang Q
Adv Healthc Mater; 2024 Apr; 13(10):e2303451. PubMed ID: 37983596
[TBL] [Abstract][Full Text] [Related]
20. Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows.
Feng W; Han X; Wang R; Gao X; Hu P; Yue W; Chen Y; Shi J
Adv Mater; 2019 Feb; 31(5):e1805919. PubMed ID: 30536723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
